Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Novartis Pharmaceuticals · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
anti-bacterial-agentscystic-fibrosis
pulmonary infections, pseudomonas aeruginosa in cystic fibrosis, tobramycin inhalation powder, cystic fibrosis, lung disease, anti-bacterial agents, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1046410
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.